722 related articles for article (PubMed ID: 20144414)
1. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
3. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
4. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
[TBL] [Abstract][Full Text] [Related]
7. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.
Thabit H; Lubina-Solomon A; Stadler M; Leelarathna L; Walkinshaw E; Pernet A; Allen JM; Iqbal A; Choudhary P; Kumareswaran K; Nodale M; Nisbet C; Wilinska ME; Barnard KD; Dunger DB; Heller SR; Amiel SA; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2014 Sep; 2(9):701-9. PubMed ID: 24943065
[TBL] [Abstract][Full Text] [Related]
8. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
[TBL] [Abstract][Full Text] [Related]
9. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
[TBL] [Abstract][Full Text] [Related]
10. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
12. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
13. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
Schmidt S; Boiroux D; Duun-Henriksen AK; Frøssing L; Skyggebjerg O; Jørgensen JB; Poulsen NK; Madsen H; Madsbad S; Nørgaard K
J Diabetes Sci Technol; 2013 Sep; 7(5):1255-64. PubMed ID: 24124952
[TBL] [Abstract][Full Text] [Related]
14. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
[TBL] [Abstract][Full Text] [Related]
15. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
16. A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.
Lee H; Buckingham BA; Wilson DM; Bequette BW
J Diabetes Sci Technol; 2009 Sep; 3(5):1082-90. PubMed ID: 20144421
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
[TBL] [Abstract][Full Text] [Related]
18. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
19. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
[TBL] [Abstract][Full Text] [Related]
20. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.
Cameron F; Niemeyer G; Wilson DM; Bequette BW; Benassi KS; Clinton P; Buckingham BA
Diabetes Technol Ther; 2014 Nov; 16(11):728-34. PubMed ID: 25259939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
